• Mutation; HGNC; 3236; EGFR; Unexplicit; Ex2-5del; Zygosity=Unspecified (PubMed=27974212).
  

PubMed=26629530; DOI=10.1016/j.ebiom.2015.08.026
Xie Y., Bergstrom T., Jiang Y.-W., Johansson P., Marinescu V.D., Lindberg N., Segerman A., Wicher G., Niklasson M., Baskaran S., Sreedharan S., Everlien I., Kastemar M., Hermansson A., Elfineh L., Libard S., Holland E.C., Hesselager G., Alafuzoff I., Westermark B., Nelander S., Forsberg-Nilsson K., Uhrbom L.
The Human Glioblastoma Cell Culture resource: validated cell models representing all molecular subtypes.
EBioMedicine 2:1351-1363(2015)

PubMed=27974212; DOI=10.1016/j.celrep.2016.11.056
Segerman A., Niklasson M., Haglund C., Bergstrom T., Jarvius M., Xie Y., Westermark A., Sonmez D., Hermansson A., Kastemar M., Naimaie-Ali Z., Nyberg F., Berglund M., Sundstrom M., Hesselager G., Uhrbom L., Gustafsson M., Larsson R., Fryknas M., Segerman B., Westermark B.
Clonal variation in drug and radiation response among glioma-initiating cells is linked to proneural-mesenchymal transition.
Cell Rep. 17:2994-3009(2016)

PubMed=28122246; DOI=10.1016/j.celrep.2017.01.003
Jiang Y.-W., Marinescu V.D., Xie Y., Jarvius M., Maturi N.P., Haglund C., Olofsson S., Lindberg N., Olofsson T., Leijonmarck C., Hesselager G., Alafuzoff I., Fryknas M., Larsson R., Nelander S., Uhrbom L.
Glioblastoma cell malignancy and drug sensitivity are affected by the cell of origin.
Cell Rep. 18:977-990(2017)